Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

or severe abdominal pain. The usual beginners' dose of Mounjaro is 2.5 milligrams once a week for the first 4 weeks [7]. Some doctors will continue to increase the dosage as much as 2.5 mg every 4 ...

But Mounjaro can cause certain conditions that have back pain or abdominal pain as symptoms. For example, Mounjaro may raise your risk of pancreatitis. Symptoms of pancreatitis may include back ...

Examples of commonly reported side effects include nausea, vomiting, abdominal pain, and diarrhea. See “What are the mild side effects of Mounjaro?” and “What are the serious side effects of ...

The actor said he lost 40 pounds taking GLP-1 medication before a negative side effect necessitated a change to a different ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...

For many struggling with weight management, new medications like Wegovy, Mounjaro, and Saxenda have been seen as ...

It is the largest study ever of the drug category—which includes Novo Nordisk’s GLP-1 treatments Ozempic and Wegovy and Eli Lilly’s dual-action GLP-1/GIP agonists Mounjaro and Zepbound.

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

Mounjaro can cause mild to moderate side effects, such as nausea, vomiting, constipation, and indigestion. According to Eli ...